Active Ingredient(s):Rilonacept FDA Approved: * February 27, 2008 Pharm Company: *REGENERON PHARMACEUTICALS Category:Anti-Inflammatory
Rilonacept, sold under the brand name Arcalyst, is a medication used to treat cryopyrin-associated periodic syndromes, including familial cold autoinflammatory syndrome, and Muckle–Wells syndrome; deficiency of interleukin-1 receptor antagonist; and recurrent pericarditis. Rilonacept is an interleukin 1 inhibitor.
Rilonacept is a dimeric fusion protein consisting of the ligand-binding domains of the extracellula...
* May have multiple approval dates, manufacturers, or labelers.
Arcalyst 160 mg/2ml Subcutaneous Injection, Powder, Lyophilized, for Solution